This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:diseases:als [01.04.2019] – [Patient experiences] sallieq | home:diseases:als [02.11.2019] – [Evidence of infectious cause] sallieq | ||
---|---|---|---|
Line 42: | Line 42: | ||
Neuropharmacology Vol.13 No 8 12 June 2002 Ludo Van Den Bosch, Petra Tilkin, Griet Lemmns and Wim Robberecht Laboratory of Neurology, Campus Gasthuisberg, | Neuropharmacology Vol.13 No 8 12 June 2002 Ludo Van Den Bosch, Petra Tilkin, Griet Lemmns and Wim Robberecht Laboratory of Neurology, Campus Gasthuisberg, | ||
- | < | + | < |
- | + | ||
- | http:// | + | |
Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," | Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," |